Literature DB >> 21309779

Characterization of Jk(a+(weak)): a new blood group phenotype associated with an altered JK*01 allele.

Elisabet S Wester1, Jill R Storry, Martin L Olsson.   

Abstract

BACKGROUND: The clinically important Kidd (JK) blood group system is considered to be relatively uncomplicated, both serologically and genetically. The JK*01 and JK*02 alleles give rise to Jk(a) and Jk(b) antigens, respectively, and silenced alleles result in Jk(a-b-). Other inherited variants analogous to Fy(x) and weak D phenotypes have not been characterized for JK, although recent abstracts indicate their presence. STUDY DESIGN AND METHODS: Six index samples from individuals whose RBCs reacted variably or weakly with different sources of anti-Jk(a) and 300 controls of the four known JK phenotypes were investigated by standard serology, flow cytometry, Western blotting, and the urea hemolysis test. Molecular analysis, including allele-specific polymerase chain reaction (PCR), DNA sequencing, and transcript analysis by real-time PCR, was performed.
RESULTS: All Jk(a+(w)b-) and Jk(a+(w)b+) index samples were homo- or heterozygous for an altered JK*01 allele carrying 130G>A (Glu44Lys) and the JK*02-associated silent SNPs 588G and Intron 9 -46g. Blood donor screening indicated an allele frequency of 0.042. Titration and flow cytometry with anti-Jk(a) gave lower values in index samples compared to controls, as did anti-Jk3 titers. Donors with 130A also showed significantly decreased Jk(a) density by flow cytometry versus 130G. Western blotting with anti-UT-B demonstrated weaker reactivity with Jk(a+(w)) membranes while JK mRNA levels could not discriminate index samples from controls. The urea hemolysis test was only moderately affected in two Jk(a+(w)b-) samples.
CONCLUSIONS: A new phenotype with weakened Jk(a) expression on RBCs is associated with a JK*01-like allele, which may constitute a risk for hemolytic transfusion reactions if antigen-positive units are missed by routine serology.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309779     DOI: 10.1111/j.1537-2995.2010.02795.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.

Authors:  Montserrat Garcia-Closas; Yuanqing Ye; Nathaniel Rothman; Jonine D Figueroa; Núria Malats; Colin P Dinney; Nilanjan Chatterjee; Ludmila Prokunina-Olsson; Zhaoming Wang; Jie Lin; Francisco X Real; Kevin B Jacobs; Dalsu Baris; Michael Thun; Immaculata De Vivo; Demetrius Albanes; Mark P Purdue; Manolis Kogevinas; Ashish M Kamat; Seth P Lerner; H Barton Grossman; Jian Gu; Xia Pu; Amy Hutchinson; Yi-Ping Fu; Laurie Burdett; Meredith Yeager; Wei Tang; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Alison Johnson; Molly Schwenn; Margaret R Karagas; Alan Schned; Gerald Andriole; Robert Grubb; Amanda Black; Eric J Jacobs; W Ryan Diver; Susan M Gapstur; Stephanie J Weinstein; Jarmo Virtamo; David J Hunter; Neil Caporaso; Maria Teresa Landi; Joseph F Fraumeni; Debra T Silverman; Stephen J Chanock; Xifeng Wu
Journal:  Hum Mol Genet       Date:  2011-08-08       Impact factor: 6.150

2.  Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease.

Authors:  Jessica Casas; David F Friedman; Tannoa Jackson; Sunitha Vege; Connie M Westhoff; Stella T Chou
Journal:  Transfusion       Date:  2015-01-09       Impact factor: 3.157

3.  Blood group typing from whole-genome sequencing data.

Authors:  Julien Paganini; Peter L Nagy; Nicholas Rouse; Philippe Gouret; Jacques Chiaroni; Chistophe Picard; Julie Di Cristofaro
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

4.  DNA sequence analysis and Jk blood group genotype-phenotype assessment.

Authors:  Shuang Liang; Yu-Qing Su; Yan-Lian Liang; Fan Wu; Hao Zhang; Jia-Hai Shi; Wen-Xu Hong; Yun-Ping Xu
Journal:  Ann Transl Med       Date:  2020-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.